Skip to main content
Health & Medicine

Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030.

| Source: Lancet (London, England)

The ongoing decline in funding for humanitarian and development assistance stands in stark contrast to the global rise in wealth concentration and widening socioeconomic inequalities. This study aimed to assess whether the implementation of wealth redistribution policies-proposed in recent high-level international agreements to support development-could mitigate the health impact of the current official development assistance (ODA) defunding crisis. We conducted an integrated retrospective impac

The ongoing decline in funding for humanitarian and development assistance stands in stark contrast to the global rise in wealth concentration and widening socioeconomic inequalities. This study aimed to assess whether the implementation of wealth redistribution policies-proposed in recent high-level international agreements to support development-could mitigate the health impact of the current official development assistance (ODA) defunding crisis. We conducted an integrated retrospective impact evaluation and forecasting analysis using longitudinal panel data from 59 low-income and lower-middle-income countries. First, we estimated the association between per-capita ODA and mortality outcomes from 2002 to 2021 using two-way fixed-effects multivariable Poisson regression models with robust standard errors, adjusting for key demographic, socioeconomic, and health-system covariates. We did extensive sensitivity and triangulation analyses to assess the robustness and plausibility of the findings. We then evaluated ten wealth redistribution policies with validated country-level microsimulation models to forecast mortality outcomes under alternative wealth redistribution scenarios versus the current defunding scenario from 2026 to 2030. In comparison with the baseline ODA category, high ODA funding was associated with a 24% reduction in age-standardised all-cause mortality (rate ratio [RR] 0·76; 95% CI 0·67-0·87) and a 33% reduction in under-5 mortality (0·67; 0·50-0·89). Forecasting analyses showed that, in comparison with the current ODA funding reductions in the 59 selected low-income and lower-middle-income countries, all ten wealth redistribution policies were associated with millions of averted deaths by 2030: overall, the lowest number of averted deaths was 6 591 984 (95% uncertainty interval 4 884 075-8 374 138) for a 3% crypto tax applied to the top 10 000 holders, while the highest number of averted deaths was 29 509 934 (20 273 842-38 603 961) for a 3% wealth tax on ultra-high-net-worth individuals; in children younger than 5 years, the corresponding numbers of averted deaths were 1 312 912 (802 926-1 785 121) for a 3% crypto tax applied to the top 10 000 holders and 3 464 607 (1 235 930-5 609 331) for a 3% wealth tax on ultra-high-net-worth individuals. The implementation of wealth redistribution policies proposed in recent high-level international agreements could mitigate the health consequences of the current ODA defunding crisis, avert millions of deaths, and support the achievement of the UN Sustainable Development Goals, particularly those related to health. Spanish Ministry of Science and Innovation.

Read the original source →

Related Stories

Health & Medicine

The honey bee stinger: An unusual pump with collapsible double pistons.

Most stinging animals deliver venom by contracting muscles around a venom reservoir, but honey bees employ a fundamentally different strategy. The stingers of worker bees have the unique ability to autotomize, separating from the body, to continue to sting independently. Despite more than a century of anatomical descriptions, the mechanics of venom pumping have remained unresolved due to the challenges of observing them in action. We recorded high-speed videos of active, autotomized stingers, co

Continue reading
Health & Medicine

Chronic cigarette smoke exposure induces distinct stem cell states driving genetic driver-specific non-small cell lung cancer subtypes.

Cigarette smoke-induced chronic inflammation (CI) potentiates development of non-small cell lung cancer (NSCLC) by mediating genetic and epigenetic events. Using normal lung organoids (LOs), we define how chronic cigarette smoke condensate (CSC) exposure drives two separate stem cell populations to evolve premalignant states harboring progressive epigenetic and linked transcriptomic abnormalities in the absence of major driver mutations. These dynamics facilitate evolution of an immune evasive s

Continue reading
Health & Medicine

Cell identity competes with surface tension to determine stromal organization in tumor spheroids beyond the CAF shell paradigm.

Cancer-associated fibroblasts (CAFs) are often found forming a peripheral stromal barrier around tumors. Here, this paradigm is challenged using microfabricated 3D cancer-CAF spheroid models combined with quantitative magnetic force tensiometry. A surface tension atlas is established for eight cancer cell lines, three CAF populations, and heterotypic tumor-CAF assemblies, spanning nearly two orders of magnitude. Surface tension is first shown to govern spheroid morphology and modulate drug respo

Continue reading
Health & Medicine

A phenome-wide structural variant map from 467,152 UK Biobank genomes.

Structural variants (SVs) are large (>50 base pairs) genomic rearrangements that can significantly influence human phenotypes, yet their contribution to health and disease remains undercharacterized. We conducted a phenome-wide association study (PheWAS) of 1.6 million SVs identified in whole-genome sequencing data from 467,152 UK Biobank participants, across 13,322 binary, 2,018 quantitative, and 2,923 plasma protein traits. Of these, 82.25% of SVs were outside the detectable range of prior

Continue reading
Health & Medicine

Mitochondria-targeted tetraoxanes initiate lipid peroxidation to drive ferroptosis and tumor suppression.

Ferroptosis is implicated as a vulnerability in multiple cancers, yet approaches for effectively inducing ferroptosis in vivo are limited. Bypassing conventional strategies targeting the antiferroptotic glutathione peroxidase 4 (GPX4) and ferroptosis suppressor protein 1 (FSP1) proteins, we designed metabolic initiators of lipid peroxidation (MILPOs) and developed the compounds WMK-1/2, which contain tetraoxane radical-generating and mitochondria-targeting groups, as de novo ferroptosis inducers

Continue reading